Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medspray is a Dutch medical technology company specializing in the development of high-precision spray nozzles for pharmaceutical drug delivery. The company's proprietary technology utilizes micro-nozzles to create monodisperse aerosols with highly controlled droplet sizes, optimizing drug deposition in the lungs, nose, or throat. Medspray Anesthesia is a dedicated division focused on providing specialized devices for targeted local anesthesia of the upper airways, enhancing patient comfort during invasive procedures. Beyond anesthesia, the company partners with global pharmaceutical firms to integrate its spray systems into soft mist inhalers and nasal delivery devices for respiratory and systemic treatments. Medspray operates a joint venture, Resyca, with Recipharm to provide end-to-end development and manufacturing services for inhaled products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medspray Anesthesia.